Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors.
Ex vivo generation and antigen loading of dendritic cells (DCs) from cancer patients helps to bypass the dysfunction of endogenous DCs. It also allows to control the process of DC maturation and to imprint in maturing DCs several functions essential for induction of effective forms of cancer immunity. Recent reports from several groups including ours demonstrate that distinct conditions of DC generation and maturation can prime DCs for preferential interaction with different (effector versus regulatory) subsets of immune cells. Moreover, differentially-generated DCs have been shown to imprint different effector mechanisms in CD4(+) and CD8(+) T cells (delivery of "signal three") and to induce their different homing properties (delivery of "signal four"). These developments allow for selective induction of tumor-specific T cells with desirable effector functions and tumor-relevant homing properties and to direct the desirable types of immune cells to tumors.
Kalinski
Pawel
P
Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15213, United States. kalinskip@upmc.edu
Okada
Hideho
H
D000818:Animals; D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use; D002454:Cell Differentiation; D002634:Chemotaxis, Leukocyte / Q000276:immunology / Q000502:physiology; D003713:Dendritic Cells / Q000166:cytology / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D051379:Mice; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D013601:T-Lymphocytes / Q000276:immunology*
D019496:Cancer Vaccines
Curr Opin Immunol. 2005 Apr;17(2):163-9
15766676
Int J Cancer. 1997 Feb 20;74(1):69-74
9036872
J Exp Med. 1996 Jan 1;183(1):87-97
8551248
Immunity. 2000 Oct;13(4):453-62
11070164
Urol Oncol. 2007 Sep-Oct;25(5):407-11
17826661
Cancer Res. 2008 Jul 15;68(14):5972-8
18632653
Int J Cancer. 2000 Sep 1;87(5):665-72
10925360
Nat Med. 2001 Dec;7(12):1339-46
11726975
Eur J Immunol. 1996 Jun;26(6):1335-41
8647214
Br J Cancer. 2003 Oct 20;89(8):1463-72
14562018
Nat Rev Immunol. 2003 Feb;3(2):133-46
12563297
Nat Rev Cancer. 2004 May;4(5):401-11
15122211
Immunol Res. 2006;36(1-3):137-46
17337774
J Immunol. 2008 Feb 15;180(4):2089-98
18250414
Cancer. 2009 Aug 15;115(16):3670-9
19536890
Immunity. 2004 Oct;21(4):458-60
15485623
Immunity. 2008 Sep 19;29(3):372-83
18799145
Semin Cancer Biol. 2004 Jun;14(3):155-60
15246050
J Clin Oncol. 2006 Jul 1;24(19):3089-94
16809734
Nat Med. 1998 Mar;4(3):328-32
9500607
Nat Med. 2004 May;10(5):475-80
15122249
J Immunol. 1993 Feb 1;150(3):1122-36
7678617
Nature. 1998 Mar 19;392(6673):245-52
9521319
Nat Med. 2004 Sep;10(9):909-15
15340416
J Exp Med. 2003 Sep 15;198(6):963-9
12963696
Immunol Cell Biol. 2005 Oct;83(5):451-61
16174093
Blood. 2002 Aug 15;100(4):1362-72
12149219
J Exp Med. 1999 Nov 15;190(10):1417-26
10562317
Clin Cancer Res. 1998 Mar;4(3):585-93
9533525
Clin Cancer Res. 2005 May 1;11(9):3363-8
15867236
J Transl Med. 2007 Feb 12;5:10
17295916
Immunol Today. 1999 Dec;20(12):561-7
10562707
Adv Cancer Res. 2004;92:13-27
15530555
Mol Immunol. 2005 Feb;42(4):535-9
15607810
Science. 2006 Sep 29;313(5795):1960-4
17008531
Breast Dis. 2004;20:137-43
15687714
Nat Rev Immunol. 2003 Dec;3(12):984-93
14647480
Cancer Sci. 2004 Sep;95(9):697-703
15471553
Immunol Rev. 1989 Apr;108:5-18
2670744
Blood. 1997 Nov 1;90(9):3640-6
9345048
Immunol Lett. 2002 Aug 1;83(1):13-20
12057850
Crit Rev Immunol. 2009;29(1):1-42
19348609
Cancer Immunol Immunother. 2008 May;57(5):685-91
17909797
J Immunol. 1990 Nov 15;145(10):3247-55
1700003
J Exp Med. 1975 Apr 1;141(4):804-20
1127378
J Immunol. 2008 Mar 15;180(6):3797-806
18322186
Blood. 2002 Jul 1;100(1):174-7
12070024
Nat Rev Drug Discov. 2009 Sep;8(9):685-6
19721436
Cancer Immunol Immunother. 2008 Nov;57(11):1589-97
18322684
Clin Cancer Res. 2004 Dec 15;10(24):8465-71
15623626
J Clin Oncol. 2009 Sep 1;27(25):4035-7
19635998
Curr Opin Immunol. 2002 Jun;14(3):360-5
11973135
Cancer Res. 2004 Nov 1;64(21):7697-701
15520172
Curr Opin Immunol. 2009 Apr;21(2):167-72
19282163
Ann N Y Acad Sci. 1999;889:72-83
10668484
Int Immunol. 1998 Nov;10(11):1593-8
9846688
Immunol Rev. 2000 Oct;177:134-40
11138771
Nat Immunol. 2005 Aug;6(8):769-76
15995707
J Clin Invest. 2005 Dec;115(12):3623-33
16308572
Nature. 1991 Feb 28;349(6312):796-9
1705666
Clin Cancer Res. 2007 Jul 1;13(13):3776-82
17606707
J Exp Med. 2002 Nov 18;196(10):1393-8
12438431
J Exp Med. 1974 Jun 1;139(6):1431-45
4598015
Cancer Immunol Immunother. 2006 Aug;55(8):958-68
16215718
Science. 2004 Jul 9;305(5681):200-5
15247469
Clin Cancer Res. 2003 Nov 1;9(14):5091-100
14613986
J Clin Invest. 1999 Jul;104(2):173-80
10411546
Cancer Lett. 2007 Oct 28;256(2):137-65
17629396
Neoplasia. 2005 Aug;7(8):717-22
16207473
Cancer Res. 2003 Jan 1;63(1):12-7
12517769
Immunity. 2004 Oct;21(4):527-38
15485630
J Immunol. 1997 Jul 1;159(1):28-35
9200435
J Neurosurg. 2002 Sep;97(3):611-8
12296646
Ann Pharmacother. 2008 Jan;42(1):91-8
18094343
Immunol Rev. 2008 Dec;226:191-204
19161425
J Immunol. 2009 Dec 1;183(11):7250-8
19915058
Cancer Res. 2006 Jun 1;66(11):5883-91
16740728
Cancer Res. 2006 Apr 15;66(8):4478-87
16618775
J Immunol. 2009 Jul 1;183(1):41-50
19535645
Annu Rev Immunol. 2000;18:593-620
10837070
Clin Cancer Res. 2003 Oct 1;9(12):4347-55
14555505
J Leukoc Biol. 2008 Jul;84(1):319-25
18426971
J Immunol. 2010 Jan 15;184(2):591-7
20018619
Immunity. 2006 Jul;25(1):19-29
16860754
Immunol Rev. 2006 Aug;212:314-29
16903923
Blood. 1997 Sep 1;90(5):1920-6
9292525
Nat Immunol. 2005 Feb;6(2):163-70
15654341
Cancer Gene Ther. 2005 Jan;12(1):72-83
15389286
Cancer Res. 2009 Feb 15;69(4):1587-95
19190335
Nat Rev Immunol. 2005 Apr;5(4):296-306
15803149
J Exp Med. 2003 Jul 21;198(2):235-47
12874257
Nat Rev Immunol. 2004 Dec;4(12):941-52
15573129
Nat Rev Immunol. 2005 Mar;5(3):251-60
15738955
Cancer Immunol Immunother. 2009 Aug;58(8):1329-36
19156413
J Pathol. 2009 Jan;217(1):21-31
18980207
Immunol Rev. 2006 Jun;211:197-202
16824128
Cancer Res. 1999 Aug 15;59(16):4035-41
10463604
Am J Clin Pathol. 2005 Jul;124(1):37-48
15923172
Eur J Immunol. 1997 Dec;27(12):3135-42
9464798
Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):727s-732s
17255301
Cancer Res. 2007 Mar 1;67(5):1883-6
17332313
J Immunother. 2009 Jun;32(5):465-73
19609238
J Immunol. 2003 Jul 1;171(1):152-8
12816993
J Immunol. 2000 May 1;164(9):4507-12
10779751
Immunol Rev. 2009 Jan;227(1):234-47
19120488
Int J Cancer. 2004 Aug 20;111(2):229-37
15197776
Expert Opin Biol Ther. 2007 Aug;7(8):1275-80
17696825
Nat Med. 1999 Apr;5(4):405-11
10202929
Prostate. 2003 Jun 1;55(4):292-8
12712408
Curr Drug Targets. 2003 Oct;4(7):525-36
14535653
J Pathol. 1999 Dec;189(4):552-8
10629557
J Neurosurg. 1978 Dec;49(6):854-61
731302
Curr Opin Immunol. 2003 Apr;15(2):138-47
12633662
Curr Allergy Asthma Rep. 2003 Jan;3(1):86-93
12543000
J Immunol. 2001 May 1;166(9):5398-406
11313376
J Exp Ther Oncol. 2002 Nov-Dec;2(6):337-49
12440225
Nat Med. 2004 Sep;10(9):942-9
15322536
Cancer Res. 2008 Jul 15;68(14):5965-71
18632652
Blood. 2001 Jun 1;97(11):3466-9
11369638
Blood. 2002 Aug 15;100(4):1354-61
12149218
J Exp Med. 1974 Feb 1;139(2):380-97
4589990
J Immunol. 2003 Sep 1;171(5):2251-61
12928369
Nature. 2003 Jul 3;424(6944):88-93
12840763
N Engl J Med. 2005 Dec 22;353(25):2654-66
16371631
Int J Cancer. 1994 Mar 15;56(6):853-7
7509778
J Immunol. 1999 Mar 15;162(6):3231-6
10092774
Curr Opin Immunol. 2002 Aug;14(4):420-31
12088675
Immunol Res. 2004;29(1-3):187-96
15181281
Clin Cancer Res. 2008 Feb 1;14(3):797-803
18245541
N Engl J Med. 1999 Jun 10;340(23):1831-3
10362830
J Immunol. 1998 Sep 15;161(6):2804-9
9743339
Br J Cancer. 1999 Mar;79(7-8):1025-31
10098731
J Invest Dermatol. 1993 Mar;100(3):269S-273S
7680054
Lancet. 2008 Mar 1;371(9614):771-83
18275997
J Exp Med. 1997 Oct 20;186(8):1183-7
9379142
Ann Oncol. 2006 Apr;17(4):563-70
16418308
Immunity. 2005 Feb;22(2):175-84
15723806
Cancer Res. 2007 Jul 1;67(13):6451-8
17616706
Annu Rev Immunol. 2007;25:267-96
17134371
J Pediatr Surg. 2001 Aug;36(8):1285-92
11479878
Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11252-7
16844772
Nat Rev Immunol. 2006 Apr;6(4):295-307
16557261
Eur J Immunol. 2008 Oct;38(10):2865-73
18958887
Nat Immunol. 2000 Oct;1(4):311-6
11017102
J Immunol. 2001 Jan 1;166(1):678-89
11123353
J Immunol. 2008 Dec 1;181(11):8053-67
19017998
J Pediatr Surg. 2003 Jun;38(6):857-62
12778381
J Immunol Methods. 1996 Sep 27;196(2):121-35
8841451
Cancer. 2005 Sep 15;104(6):1246-54
16078259
J Immunother. 2007 Jan;30(1):75-82
17198085
Cancer Res. 2004 Sep 1;64(17):5934-7
15342370
Vaccine. 2007 Oct 10;25(41):7145-52
17719152
Nature. 2007 Sep 27;449(7161):419-26
17898760
Blood. 2006 Oct 15;108(8):2655-61
16763205
Nat Med. 1998 Nov;4(11):1321-4
9809559
Immunology. 2002 Sep;107(1):28-38
12225360
Exp Biol Med (Maywood). 2008 May;233(5):522-34
18375829
Annu Rev Immunol. 2004;22:745-63
15032595
Drugs R D. 2006;7(3):197-201
16752945
J Exp Med. 2005 Jan 17;201(2):303-16
15642741
J Invest Dermatol. 2002 Jun;118(6):915-22
12060384
Expert Opin Biol Ther. 2005 Oct;5(10):1303-15
16197336
Ann Neurol. 1978 Sep;4(3):219-24
718133
Eur J Immunol. 2002 May;32(5):1445-54
11981833
J Exp Med. 2007 Jan 22;204(1):191-201
17210729
Nat Immunol. 2007 Mar;8(3):285-93
17259988
Cancer Res. 2005 Nov 1;65(21):10059-67
16267032
Curr Opin Oncol. 2009 May;21(3):260-5
19363343
Blood. 2006 Mar 15;107(6):2432-9
16291589
J Exp Med. 1973 May 1;137(5):1142-62
4573839
Cancer Res. 2000 Jul 1;60(13):3559-68
10910069
J Immunol. 2002 Jan 1;168(1):216-23
11751965
J Exp Med. 2002 Feb 18;195(4):473-83
11854360
Curr Opin Immunol. 2006 Apr;18(2):201-5
16464565
Curr Opin Immunol. 2005 Apr;17(2):170-4
15766677
Eur J Immunol. 2007 Jun;37(6):1678-90
17492620
Crit Rev Immunol. 2001;21(1-3):157-78
11642602
Nat Med. 1996 Jan;2(1):52-8
8564842
J Immunol. 2008 Jul 1;181(1):104-8
18566374
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2736-41
12598658
J Immunol. 2003 Sep 1;171(5):2366-73
12928383
Clin Cancer Res. 2000 May;6(5):1755-66
10815894
Curr Opin Immunol. 2004 Dec;16(6):724-31
15511664